Merck

Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo
Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo
BioSpace
Merck
Seagen
Astellas
urothelial cancer
clinical trials
bladder cancer
Padcev
Keytruda
Flag link:
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Merck
Eisai
Keytruda
Lenvima
melanoma
colorectal cancer
non-small cell lung cancer
Flag link:
Merck (MRK) Keytruda Cervical Cancer sBLA Gets FDA Priority Tag
Merck (MRK) Keytruda Cervical Cancer sBLA Gets FDA Priority Tag
Yahoo/Zacks.com
Merck
Keytruda
FDA
cervical cancer
priority review
Flag link:
1ST Biotherapeutics and Merck to assess cancer combination treatment
1ST Biotherapeutics and Merck to assess cancer combination treatment
Clinical Trials Arena
Merck
1st Biotherapeutics
Keytruda
solid tumors
clinical trials
Flag link:
HHS argues Merck 'lacks standing' to sue over Medicare price negotiations
HHS argues Merck 'lacks standing' to sue over Medicare price negotiations
Fierce Pharma
Merck
Inflation Reduction Act
HHS
legal
Flag link:
Merck keeps pumping up sotatercept, posting fresh data ahead of FDA approval ruling
Merck keeps pumping up sotatercept, posting fresh data ahead of FDA approval ruling
Fierce Biotech
Merck
sotatercept
FDA
cardiovascular disease
Flag link:
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
M&A
patent cliffs
Merck
JNJ
Pfizer
GSK
Novartis
Eli Lilly
Novo Nordisk
Flag link:
The 10 highest value R&D projects in biopharma
The 10 highest value R&D projects in biopharma
Fierce Biotech
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Flag link:
5 of the best places to work in pharma, according to employees
5 of the best places to work in pharma, according to employees
Pharma Voice
Glassdoor
Merck
JNJ
Pfizer
GSK
Sanofi
Flag link:
Merck Initiates Phase 3 Clinical Program for Oral PCSK9 Inhibitor Candidate MK-0616
Merck Initiates Phase 3 Clinical Program for Oral PCSK9 Inhibitor Candidate MK-0616
Drugs.com
Merck
clinical trials
MK-0616
hypercholesterolemia
Flag link:
Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer
Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer
BioSpace
Merck
Eisai
Keytruda
Lenvima
clinical trials
head and neck cancer
Flag link:
Merck bets big on oral PCSK9 inhibitor, putting 6-year outcome study at heart of phase 3 program
Merck bets big on oral PCSK9 inhibitor, putting 6-year outcome study at heart of phase 3 program
Fierce Biotech
Merck
PCSK9 inhibitors
clinical trials
cardiovascular disease
cholesterol
MK-0616
Flag link:
Merck’s Keytruda to top drug sales in 2028, as Roche takes pharma crown
Merck’s Keytruda to top drug sales in 2028, as Roche takes pharma crown
Medical Marketing and Media
Merck
Keytruda
Roche
branding
Flag link:
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
patent cliff
patents
Takeda
Vyvanse
Pfizer
Eraxis
JNJ
Stelara
Merck
Isentress
Eiger Pharmaceuticals
Zokinvy
Astellas
Myrbetriq
Novartis
Entresto
Amgen
Otzela
Flag link:
Merck's Keytruda will top pharma's sales rankings in 2028, with Roche taking the company category crown
Merck's Keytruda will top pharma's sales rankings in 2028, with Roche taking the company category crown
Fierce Pharma
Merck
Roche
pharma sales
Keytruda
Flag link:
Merck’s Welireg Clears Phase III Primary Endpoint in Renal Cell Carcinoma
Merck’s Welireg Clears Phase III Primary Endpoint in Renal Cell Carcinoma
BioSpace
Merck
Welireg
renal cell carcinoma
clinical trials
Flag link:
Gilead antibody drug shows signs of potential in early lung cancer
Gilead antibody drug shows signs of potential in early lung cancer
BioPharma Dive
Gilead Sciences
Trodelvy
Merck
Keytruda
lung cancer
Flag link:
The 10 drugs that CMS might wrangle into negotiations
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
CMS
Medicare
drug pricing
Bristol Myers Squibb
Janssen
Merck
Pfizer
Amgen
Boehringer Ingelheim
Pharmacyclics
AstraZeneca
Astellas
GSK
Flag link:
Merck and Astex announce expansion to oncology drug discovery collaboration
Merck and Astex announce expansion to oncology drug discovery collaboration
Pharma Live
Merck
Astex
drug discovery
small molecule drugs
Flag link:
US FDA approves Merck’s Ebola vaccine for under-18s
US FDA approves Merck’s Ebola vaccine for under-18s
Pharmaceutical Technology
Merck
ebola virus
vaccines
Ervebo
pediatric
Flag link:

Pages